Skip to main content
. 2021 Nov 3;35(6):3345–3353. doi: 10.21873/invivo.12632

Table II. Evaluation of values of PMPs, RMPs, and MP-activity in MPN patients according to the presence of thrombotic risk factors and in relation to blood count.

graphic file with name in_vivo-35-3348-i0001.jpg

1Values denote median and interquartile range. MPs: Microparticles; PMPs: platelet microparticles; RMPs: erythrocyte microparticles; MP-activity: procoagulant activity of microparticles. *p<0.05, **p<0.01, ***p<0.001.